DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Healthcare Digital Experience Platform Market By Component, By Application, By Delivery Mode, By Country, Opportunity Analysis and Industry Forecast, 2021-2027” report has been added to ResearchAndMarkets.com’s offering.
The Asia Pacific Healthcare Digital Experience Platform Market is expected to witness market growth of 14.6% CAGR during the forecast period (2021-2027).
The goal of end-user customisation is to make it easier for everyone to utilise the system by allowing them to modify their experience to some extent. A hospital will be capable of improving a broad array of different aspects of the digital experience by implementing a DXP. These platforms give the hospital a great deal of control over the numerous parts that make up its online presence.
Content management, application integration, analytics and optimization, workflow management, security administration, patient experience, and more are all included in this platform. The architecture of a platform is its technical foundation. A hospital can acquire more control over patient and staff data by developing new tools and linking existing apps to the DXP. It also impacts how quickly a user can transit between tools for a more productive and efficient experience.
According to Beijing, China’s senior population has over 180 million people dealing with chronic conditions in 2019. Furthermore, Omron Healthcare, a subsidiary of Omron Corporation, debuted the Heart Guide, the first wearable blood pressure monitor with digital health service, in January 2019. As a result, the market’s growth is fuelled by the presence of key companies in healthcare digital experience platform & technologies and the growing elderly population.
The China market dominated the Asia Pacific Healthcare Digital Experience Platform Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $188.1 million by 2027. The Japan market is anticipated to grow a CAGR of 13.9% during (2021 – 2027). Additionally, The India market is expected to showcase a CAGR of 15.3% during (2021 – 2027).
Based on Component, the market is segmented into Platform (without services), and Services. Based on Application, the market is segmented into Business-to-Consumer (B2C), Business-to-Business (B2B), and Others. Based on Delivery Mode, the market is segmented into Cloud and On-premise. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Scope of the Study
Market Segments Covered in the Report:
By Component
By Application
By Delivery Mode
By Country
Key Market Players
List of Companies Profiled in the Report:
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis – Global
Chapter 4. Asia Pacific Healthcare Digital Experience Platform Market by Component
Chapter 5. Asia Pacific Healthcare Digital Experience Platform Market by Application
Chapter 6. Asia Pacific Healthcare Digital Experience Platform Market by Delivery Mode
Chapter 7. Asia Pacific Healthcare Digital Experience Platform Market by Country
Chapter 8. Company Profiles
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/4t8wdp
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…
Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…
QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…
SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…
DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…
Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…
